Stock listing

B3:E1WL34 Edwards Lifesciences Corporation Ações

Brazilian listing (B3) of Edwards Lifesciences Corporation · home listing NYSE:EW

Follow Edwards Lifesciences Corporation into a list and get an email when it puts out news.

Share price · BMFBOVESPA:E1WL34

104.50 BRL 0.00 (0.0%)

Close on Oct 19, 2026

Day range
104.50 – 104.50 BRLOct 19, 2026
Edwards Lifesciences Corporation logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NYSE:EW · Home$88.29 USD+1.07 (+1.2%)1,795,549$87.73$88.34$87.16$87.22Close on Oct 20, 2026
Xetra:EWL€77.98 EUR+0.72 (+0.9%)24€76.80€77.98€76.80€77.26Close on Oct 19, 2026
BMV:EW$2,317.75 MXN+8.48 (+0.4%)—$2,309.27$2,339.18$2,309.27$2,309.27Close on Oct 20, 2026
Frankfurt:EWL€78.40 EUR+0.60 (+0.8%)130€77.42€78.50€77.42€77.80Close on Oct 20, 2026
B3:E1WL34104.50 BRL0.00 (0.0%)—104.50104.50104.50104.50Close on Oct 19, 2026
Ticker
B3:E1WL34
Asset type
Stock
Sector
Health care
Industry
Medical devices & supplies
Exchange
B3
Currency
BRL

What changed lately

Calls

Replays

  • Edwards Lifesciences (NYSE:EW) Q2 2026 Earnings Call

    Thu, Jul 23, 2026 · 5:00 PM ET

    Watch Transcript

  • Edwards Lifesciences (NYSE:EW) Q1 2026 Earnings Call

    Thu, Apr 23, 2026 · 2:00 PM ET

    Watch Transcript

  • Edwards Lifesciences (NYSE:EW) Q4 2025 Earnings Call

    Tue, Feb 10, 2026 · 5:00 PM ET

    Watch Transcript

Latest news

Edwards Lifesciences to Host Earnings Conference Call on November 4, 2026

Oct 7, 2026

Edwards Lifesciences to Host Investor Event in Conjunction With TCT

Oct 5, 2026

Edwards Lifesciences Receives FDA Approval for AUTUS Valve, the First Surgical Pulmonary Valve for Pediatric Patients

Oct 1, 2026

Edwards Lifesciences Comments on TAVR National Coverage Decision

Sep 10, 2026

Edwards Lifesciences to Present at the Deutsche Bank Healthcare Summit

Sep 2, 2026

Putting Patients at the Heart of Innovation: Voices Across Asia Pacific Help Shape the Future of Structural Heart Care

Aug 19, 2026

Edwards Lifesciences to Host Earnings Conference Call on July 23, 2026

Jul 16, 2026

Edwards’ Structural Heart Leadership Demonstrated Through Expanding Body of Scientific Evidence at New York Valves

Jun 26, 2026

Edwards Lifesciences Announces Appointment of CFO

May 4, 2026

Ten-year pivotal data reinforce the long-term durability of Edwards' RESILIA tissue

May 4, 2026

All Edwards Lifesciences Corporation news

Decks

Edwards Lifesciences Corporation on 6ix

Sector
Health care
Industry
Medical devices & supplies
News releases
31 in the last 12 months · 46 in all · newest Oct 7, 2026 · oldest 2025
Calls
30 calls with a replay · 30 with a transcript · latest Jul 23, 2026
Decks
29 decks · latest Jul 23, 2026

Where Edwards Lifesciences Corporation is listed

ListingExchangeCountryCurrency
NYSE:EW · Home listingNYSEUnited StatesUSD
Tradegate:EWLTradegateGermanyEUR
gettex:EWLgettexGermanyEUR
Xetra:EWLXetraGermanyEUR
BMV:EWBMVMexicoMXN
LS Exchange:936853LS ExchangeGermanyEUR
Stuttgart:EWLStuttgartGermanyEUR
Frankfurt:EWLFrankfurtGermanyEUR
Lang & Schwarz:936853Lang & SchwarzGermanyEUR
B3:E1WL34 · This pageB3BrazilBRL
Milan:1EWMilanItalyEUR
BIVA:EWBIVAMexicoMXN
EUROTLX:4EWEUROTLXItalyEUR
SIX Swiss:EWSIX SwissSwitzerlandCHF
Munich:EWLMunichGermanyEUR
Hamburg:EWLHamburgGermanyEUR
BOATS:EWBOATSUnited StatesUSD
Dusseldorf:EWLDusseldorfGermanyEUR
VIE:EWLSViennaAustriaEUR
BX Swiss:EWLBX SwissSwitzerlandCHF
LSE:0RENLSEUnited KingdomCHF
SIX Swiss:EW.USDSIX SwissSwitzerlandUSD
Hanover:EWLHanoverGermanyEUR

Log in to ask 6ix AI your own questions about Edwards Lifesciences Corporation.